The Neuroprotective Agent DP‐b99 Does Not Interact with S‐warfarin In Vivo Despite Significant CYP2C9 Inhibition In Vitro

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Basic & clinical pharmacology & toxicology 2011-04, Vol.108 (4), p.289-292
Hauptverfasser:	Rosenberg, Gilad, Marshall, Linda S., Caraco, Yoseph
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Anticoagulants - administration & dosage Anticoagulants - pharmacology Aryl Hydrocarbon Hydroxylases - antagonists & inhibitors Aryl Hydrocarbon Hydroxylases - genetics Biological and medical sciences Cross-Over Studies Cytochrome P-450 CYP2C9 Dose-Response Relationship, Drug Double-Blind Method Drug Interactions Egtazic Acid - administration & dosage Egtazic Acid - analogs & derivatives Egtazic Acid - pharmacology Genotype Humans Male Medical sciences Neuroprotective Agents - administration & dosage Neuroprotective Agents - pharmacology Pharmacology. Drug treatments Warfarin - administration & dosage Warfarin - pharmacology Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!